“Issuance of the new patent for our oncology preclinical aPKCi inhibitor pipeline is an important part of our development strategy,” said Jed Latkin, CEO of Windtree Therapeutics. “We will continue ...
The risk for melanoma, lung cancer, and bladder cancer was lower among patients with vitiligo in a secondary ... Vitiligo has recently been acknowledged for its broader influence across body systems, ...